GKOS Latest Press Releases

-- July 8, 2026 --

Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29 Business Wire 7:00 AM

-- June 25, 2026 --

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis Business Wire 7:00 AM

-- May 12, 2026 --

Glaukos Announces Participation in Upcoming Investor Conferences Business Wire 7:00 AM

-- April 29, 2026 --

Glaukos Announces First Quarter 2026 Financial Results Business Wire 4:05 PM

-- April 16, 2026 --

Glaukos Announces the Release of its 2025 Sustainability Report Business Wire 7:00 AM

-- April 15, 2026 --

Glaukos Receives Permanent J-code for Epioxa Business Wire 4:05 PM

-- April 8, 2026 --

Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29 Business Wire 7:00 AM

-- April 6, 2026 --

Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Business Wire 7:00 AM

-- March 19, 2026 --

Glaukos Announces Commercial Availability of Epioxa , a Transformative Innovation in Interventional Keratoconus Care Business Wire 7:00 AM

-- February 17, 2026 --

Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results Business Wire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software